Showing results (21-30 of 41) with videos related to
Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry Letters|February 16, 2008
Substituted 2,2-bisaryl-bicycloheptanes as novel and potent inhibitors of 5-lipoxygenase activating proteinDwight Macdonald, Christine Brideau, Chi Chung Chan, et al.Bioorganic & Medicinal Chemistry Letters|November 11, 2011
Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of spirocyclic piperidinesAustin Chen, Renee Aspiotis, Louis-Charles Campeau, et al.Journal of Medicinal Chemistry|August 9, 2003
A novel class of nonpeptidic biaryl inhibitors of human cathepsin KJoël Robichaud, Renata Oballa, Peppi Prasit, et al.Bioorganic & Medicinal Chemistry Letters|February 9, 2006
Substituted coumarins as potent 5-lipoxygenase inhibitorsErich L Grimm, Christine Brideau, Nathalie Chauret, et al.Bioorganic & Medicinal Chemistry Letters|September 13, 2005
Trifluoroethylamines as amide isosteres in inhibitors of cathepsin KW Cameron Black, Christopher I Bayly, Dana E Davis, et al.American Journal of Respiratory Cell and Molecular Biology|February 9, 2008
Adenovirus IL-13-induced airway disease in mice: a corticosteroid-resistant model of severe asthmaAlex G Therien, Virginie Bernier, Sean Weicker, et al.Bioorganic & Medicinal Chemistry Letters|February 14, 2012
3,4-Diarylpiperidines as potent renin inhibitorsPatrick Lacombe, Mélissa Arbour, Renée Aspiotis, et al.Bioorganic & Medicinal Chemistry Letters|March 25, 2011
The discovery and synthesis of potent zwitterionic inhibitors of reninRenee Aspiotis, Austin Chen, Elizabeth Cauchon, et al.ACS Medicinal Chemistry Letters|February 18, 2026
Design of a Targeted Covalent Probe to Interrogate the DNA Polymerase Activity of PolθMonica Bubenik, Pavel Mader, Stephen Orlicky, et al.Antimicrobial Agents and Chemotherapy|January 1, 2014
In vitro characterization of MK-1439, a novel HIV-1 nonnucleoside reverse transcriptase inhibitorMing-Tain Lai, Meizhen Feng, Jean-Pierre Falgueyret, et al.Pageof 5